China Health Industries Holdings

CHHE · OTC

$0.0001+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.

About CHHE

China Health Industries Holdings, Inc. engages in the production, marketing, and distribution of medicines, health products, health devices, and cosmetics. The company is headquartered in Harbin, Heilongjiang and currently employs 32 full-time employees. The company went IPO on 2004-12-01. The firm's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The firm's products include soft capsule, hard capsule, tablet, granule, oral liquid forms which address the needs of some key sectors in China, including the feminine, geriatric, and children’s markets.

Employees
33
Headquarters
Harbin, Heilongjiang
Listed
Dec 1, 2004
Sector
Consumer Staples
Industry
Personal Care Products

Leadership

China Health Industries Holdings executives
NameTitleSince
Xin Sun—2007
Baosen Ma—2004
Kai Sun——
Melody Zhang——

Revenue by product and region

Fiscal year ended Jun 30, 2023: $111.58K total revenue

By region

  • Consolidated operations [Member]$111.60K100.0%
  • Humankind [Member]$111.60K100.0%

Similar companies

Companies in the same industry as China Health Industries Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.